Healthcare -
Biotechnology - NASDAQ - IE
$ 34.775
1.3 %
$ 5.65 B
Market Cap
15.81
P/E
Price Target
Average
2.88%
Revenue Forecast
Estimate
--0.45%
EBIT
Estimate
--21.59%
Net Income
Estimate
--2.57%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alkermes plc
Wall Street analysts predict an average 1-year price target for ALKS of $35.8 , with forecasts ranging from
a
low of
$25 to a high of $50 .
ALKS Lowest Price Target
Wall Street Target
25 USD
-28.11%
ALKS Average Price Target
Wall Street Target
35.8 USD
2.88%
ALKS Highest Price Target
Wall Street Target
50 USD
43.78%
REVENUE FORECAST
Revenue Forecast Chart ALKS
EBIT FORECAST
EBIT Forecast Chart ALKS
NET INCOME FORECAST
Net Income Chart ALKS